The new recommendations could provide innovative treatments for cancer patients more quickly

new complex innovative design (complex innovation design) trial proposal has been published in Cancer UK and, if implemented, could ultimately reduce the time it takes cancer patients to get "innovative" treatment.As a result, the trial's authors called on clinicians, funders, regulators and the pharmaceutical industry to support the ten recommendations and work together to implement them as quickly as possible.Each recommendation covers specific stages of the clinical trial pathway, including trial planning and design, program development, patient and public engagement, patient-facing documentation, and more.The authors say the recommendations could improve the conduct, quality and acceptability of complex innovative design trials in oncology in clinical studies, as well as improve how different stakeholders interact to promote and share their experiences in complex innovative design research.Complex and innovative design methods enable researchers to conduct more complex trials to solve multiple clinical problems at once. Unfortunately, there may be challenges, and the team does not currently have practical guidelines for funding, designing and conducting such trials in Europe.The researchers say the recommendations could improve the conduct, quality and acceptability of complex innovative design trials for tumors in clinical studies, as well as improve how different stakeholders interact to promote and share their experiences from the study.Nick Lemoine, NIHR's medical director, says it can take some time to get promising new cancer treatments for patients who need their treatment most, so speeding up the process through complex, innovative design trials is imperative.He continued: "With the expertise and new guidelines in the ECMC network, the UK is now one of the most well-developed countries to conduct these trials, which represents the future of assessing new cancer drugs. " researchers are increasingly using complex innovative design trials as an assessment method rather than as a traditional approach to drug development (involving clinical trials from Phase I to Phase IV). （cyy123.com）